Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study.

Falcini F, Capannini S, Martini G, La Torre F, Vitale A, Mangiantini F, Nacci F, Cerinic MM, Cimaz R, Zulian F.

Lupus. 2009 Feb;18(2):139-43. doi: 10.1177/0961203308094999.

PMID:
19151115
2.

Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.

Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.

Ren Fail. 2008;30(9):865-9. doi: 10.1080/08860220802353843.

PMID:
18925525
3.

Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.

Dittrich K, Ross S, Benz K, Amann K, Dötsch J.

Klin Padiatr. 2009 Dec;221(7):425-9. doi: 10.1055/s-0029-1234130. Epub .

PMID:
20013565
4.

Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.

Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR.

J Rheumatol. 2005 Jun;32(6):1047-52.

PMID:
15940766
5.

Lupus nephritis: treatment with mycophenolate mofetil.

Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutsopoulos HM.

Rheumatology (Oxford). 2004 Mar;43(3):377-80. Epub 2004 Jan 6.

6.

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.

Weng MY, Weng CT, Liu MF.

Clin Rheumatol. 2010 Jul;29(7):771-5. doi: 10.1007/s10067-010-1403-9. Epub 2010 Mar 2.

PMID:
20195879
7.

The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis.

Koo HS, Kim YC, Lee SW, Kim DK, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ.

Lupus. 2011 Nov;20(13):1442-9. doi: 10.1177/0961203311416034. Epub 2011 Sep 27.

PMID:
21951944
8.

Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.

Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.

Mod Rheumatol. 2015 Mar;25(2):210-4. doi: 10.3109/14397595.2014.950810. Epub 2014 Aug 27.

PMID:
25159157
9.

Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen.

Fujinaga S, Ohtomo Y, Hara S, Umino D, Someya T, Shimizu T, Kaneko K.

Pediatr Nephrol. 2008 Oct;23(10):1877-82. doi: 10.1007/s00467-008-0800-7. Epub 2008 Apr 15.

PMID:
18414900
10.

Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.

Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.

Arch Med Res. 2008 Jan;39(1):115-9. Epub 2007 Oct 23.

PMID:
18068004
11.

Mycophenolate mofetil treatment in children and adolescents with lupus.

Kazyra I, Pilkington C, Marks SD, Tullus K.

Arch Dis Child. 2010 Dec;95(12):1059-61. doi: 10.1136/adc.2009.178608. Epub 2010 Aug 31.

PMID:
20810399
12.

Current therapies for lupus nephritis in an ethnically heterogeneous cohort.

Rivera TL, Belmont HM, Malani S, Latorre M, Benton L, Weisstuch J, Barisoni L, Tseng CE, Izmirly PM, Buyon JP, Askanase AD.

J Rheumatol. 2009 Feb;36(2):298-305. doi: 10.3899/jrheum.080335.

PMID:
19040310
13.

The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis.

Paydas S, Kurt C, Taskapan H, Balal M, Sertdemir Y, Pembegul I.

Int Urol Nephrol. 2009;41(1):145-52. doi: 10.1007/s11255-008-9454-4. Epub 2008 Sep 3.

PMID:
18766457
14.

Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.

Lourdudoss C, Vollenhoven Rv.

Lupus. 2014 Mar;23(3):299-304. doi: 10.1177/0961203313519158. Epub 2014 Jan 7.

PMID:
24399811
15.

A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.

F L, Y T, X P, L W, H W, Z S, H Z, Z H; MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.

Lupus. 2008 Jul;17(7):622-9. doi: 10.1177/0961203308089428.

PMID:
18625634
16.

Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.

Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.

J Rheumatol. 2001 Sep;28(9):2103-8.

PMID:
11550982
17.

Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis.

Laskari K, Tzioufas AG, Antoniou A, Moutsopoulos HM.

J Rheumatol. 2011 Jul;38(7):1304-8. doi: 10.3899/jrheum.101249. Epub 2011 Apr 15.

PMID:
21498485
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk